Search Results for: stem cells for MS

Australia takes big step to curtail dangerous stem cell clinics

Australia-stem-cell-clinics

The ability of for-profit stem cell clinics to pitch unproven, risky stem cell offerings to patients may soon get much tougher in Australia. The country’s Therapeutic Goods Administration (TGA), which has some similar responsibilities there as the FDA does here in the U.S., announced planned new reforms that’ll put stem cell clinics under more scrutiny and more […]

Australia takes big step to curtail dangerous stem cell clinics Read More »

Stem cell treatment cost: you often don’t get what you pay for

stem-cell-treatment-cost

How much does a stem cell treatment cost? $5,000 is a nice round number that is probably close to the mark on average, but the price varies a great deal and depends on many factors. Factors that influence perceived average price include what one actually sees as being under that umbrella term “stem cell treatment.” Does

Stem cell treatment cost: you often don’t get what you pay for Read More »

ViaCyte Interview on Diabetes Stem Cell Trials & Cool Role of Gore-Tex Tech

ViaCyte, cell therapy for diabetes

When I think of the promise of stem cells for diabetes, the privately held California stem cell firm ViaCyte is the first biotech that comes to mind now. It has promising stem cell clinical trial work building. Today’s post is a new interview with the company’s CEO Paul Laikind. For past posts on ViaCyte see here, which

ViaCyte Interview on Diabetes Stem Cell Trials & Cool Role of Gore-Tex Tech Read More »

TGIF stem cell weekend reads of papers & news

TGIF-science-dart-board

Bulls-eye! Here are some stem cell weekend reads including both interesting new papers & news headlines. Of course, this week also had stem cell awareness day and I wrote about 10 key issues for the field for the coming 10 years! Weekend reads Papers Chromatin and Single-Cell RNA-Seq Profiling Reveal Dynamic Signaling and Metabolic Transitions during

TGIF stem cell weekend reads of papers & news Read More »

Reactions to California’s new stem cell law on non-FDA approved clinic offerings

stem-cell-clinics-southern-california-e1471543154180

What does the wide stem cell and regenerative medicine community think of California’s new stem cell law requiring that clinics selling non-FDA approved stem cell offerings make specific disclosures to prospective customers and that the state medical board keep track of how this all unfolds? You probably already know that I am supportive of the

Reactions to California’s new stem cell law on non-FDA approved clinic offerings Read More »

New FDA Inspection 483s: Insights on Stem Cell Clinic & Cell Surgical Network

Cell-Surgical-Network-Founders

Two new FDA inspection reports called 483s provide fresh insights on a stem cell clinic, the network of clinics that it belongs to, and adverse events in patients. These reports detail issues the FDA found at the stem cell clinic California Stem Cell Treatment Center and its parent chain of clinics, Cell Surgical Network. The

New FDA Inspection 483s: Insights on Stem Cell Clinic & Cell Surgical Network Read More »

Customers rate Nervana stem cell clinic harshly on Yelp

Nervana-Yelp

Sacramento’s Nervana stem cell clinic has been selling non-FDA approved stem cell therapies to patients for a variety of conditions including arthritis, pain, and neuropathy for a while now since last year, but in my opinion there isn’t good evidence to back up using amniotic or fat stem cells for such conditions. Further, my understanding

Customers rate Nervana stem cell clinic harshly on Yelp Read More »